Physician

Michael A Gold, MD

According to 2025 Medicare claims, Michael Gold, MD (NPI: 1376511956) practices gynecologist/oncologist in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236.

Gold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 472 traditional Medicare patients, billed 109,769 HCPCS/CPT codes, and received $1,381,851 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 710 prescription claims across 176 beneficiaries totaling $431,076 in drug costs, led by Mekinist (Trametinib Dimethyl Sulfoxide). Open Payments data shows 51 records totaling $85,226. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $761,881 and ending at $1,381,851. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $16,425 to $431,076. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2015 Medicare payment: $761,881 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,257,746 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,375,953 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,375,854 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,617,182 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,971,430 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,027,699 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,242,664 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,699,323 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,381,851 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201546794,292$761,881
2016789192,546$2,257,746
2017557103,916$1,375,953
201856793,032$1,375,854
201970991,547$1,617,182
2020760126,156$1,971,430
2021717126,045$2,027,699
202250875,590$1,242,664
2023462113,273$1,699,323
2024472109,769$1,381,851

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$306K$613K2015 Drug cost: $16,425 (USD; Tot_Drug_Cst)2016 Drug cost: $19,440 (USD; Tot_Drug_Cst)2017 Drug cost: $29,234 (USD; Tot_Drug_Cst)2018 Drug cost: $112,334 (USD; Tot_Drug_Cst)2019 Drug cost: $428,158 (USD; Tot_Drug_Cst)2020 Drug cost: $375,097 (USD; Tot_Drug_Cst)2021 Drug cost: $516,439 (USD; Tot_Drug_Cst)2022 Drug cost: $405,797 (USD; Tot_Drug_Cst)2023 Drug cost: $612,716 (USD; Tot_Drug_Cst)2024 Drug cost: $431,076 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015125433$16,425
2016180653$19,440
2017132635$29,234
2018141764$112,334
2019142831$428,158
2020156647$375,097
2021172764$516,439
2022183850$405,797
2023190846$612,716
2024176710$431,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less114207$86
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less7895$42
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less105308$20
96372Injection of drug or substance under skin or into muscle79113$10
J1100Injection, dexamethasone sodium phosphate, 1 mg921,968$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MekinistTrametinib Dimethyl Sulfoxide12360$152,851
LynparzaOlaparib13390$150,198
Megestrol AcetateMegestrol Acetate331,830$3,001
Clobetasol PropionateClobetasol Propionate371,071$1,837
Ondansetron HclOndansetron Hcl40338$965

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$2,155AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.46$83,071GlaxoSmithKline, LLC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael A. Gold, MD?

Tedicare shows public-source Medicare data for Michael A. Gold, MD (NPI 1376511956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Gold, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Gold, MD?

Michael A. Gold, MD is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Michael A. Gold, MD have Open Payments data?

Michael A. Gold, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.